Glycogen storage diseases

Glycogen storage diseases are a group of rare inherited metabolic disorders in which the body cannot properly store or break down glycogen, the storage form of glucose, due to a missing or faulty enzyme. There are several distinct types, numbered I through at least XV, each caused by a different enzyme defect and affecting different organs, chiefly the liver and muscles. Symptoms and severity vary widely between types.

Each type is caused by an inherited mutation in a specific gene coding for an enzyme involved in glycogen metabolism, most following an autosomal recessive pattern. Because they are genetic, they are present from birth even if diagnosed later. There is no environmental or lifestyle cause.

Symptoms depend on the specific type: liver-predominant types typically cause low blood sugar and an enlarged liver, while muscle-predominant types cause exercise intolerance, cramping, and sometimes progressive weakness. Some types affect both the liver and muscle, or other organs such as the heart. Age of onset also varies, from infancy to adulthood depending on the type.

Severity varies considerably by type, ranging from conditions compatible with a near-normal life with good management, to those causing significant early complications affecting growth, the liver, or the heart. Early diagnosis and specialist metabolic care improve outcomes across all types. Regular monitoring is needed lifelong regardless of severity.

Yes, all types are inherited genetic conditions, most following an autosomal recessive pattern requiring a faulty gene copy from each parent. Genetic testing can identify the specific gene involved and inform family planning decisions. Carrier testing can be offered to relatives of an affected person.

Treatment is tailored to the specific type but often centres on dietary management to prevent low blood sugar and support energy needs, such as frequent feeding, cornstarch supplementation, or a high-protein diet. Some types benefit from enzyme replacement therapy. Specialist metabolic teams coordinate ongoing monitoring and adjust treatment as needs change with age.

There is currently no cure for any type, but modern dietary and medical management has greatly improved outcomes and quality of life for most patients. Some types, particularly liver-predominant forms, tend to improve somewhat after childhood. Research into enzyme and gene-based therapies is ongoing for several types.

The types are broadly grouped into those mainly affecting the liver, causing low blood sugar, and those mainly affecting muscle, causing exercise intolerance and weakness, though some types affect both. Type I is the most common liver-predominant form, and type V (McArdle disease) is a well-known muscle-predominant form. The specific type is identified through enzyme testing or genetic analysis, which then guides the tailored treatment plan.

Outlook varies significantly by type, but with early diagnosis and consistent specialist care, many people live long, active lives, particularly with the more common liver-predominant types. Lifelong monitoring for organ-specific complications, such as liver, kidney, or heart involvement, remains important. A metabolic specialist can give an outlook specific to the exact type diagnosed.

See a doctor if there is a pattern of recurrent low blood sugar, unexplained liver enlargement, or exercise intolerance with muscle cramping, particularly with a family history of a similar condition. A private paediatric or adult metabolic specialist referral can typically be arranged within about two weeks for initial assessment and testing. Early diagnosis allows dietary and medical management to start before complications develop.